Meeting Summary – February 2022: Buprenorphine Selection

May 5, 2022 | Meeting Summary

Article

Gryczynski, J., Jaffe, J. H., Schwartz, R. P., Dusek, K. A., Gugsa, N., Monroe, C. L., O’Grady, K. E., Olsen, Y. K., & Mitchell, S. G. (2013). Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal-Access System. The American Journal on Addictions, 22, 285-291. doi: 10.1111/j.1521-0391.2012.12004.x

Article Summary

This article explores the patient preferences regarding choice of Buprenorphine over Methadone when both medications are accessible. The members of this research team collected both qualitative and quantitative data from participants at two outpatient substance use treatment programs in Baltimore, MD. The sample of participants used in this study were predominantly African American individuals who used heroin who were also starting buprenorphine treatment. Qualitative interviews with the participants were transcribed and coded for themes relating to selection of buprenorphine treatment over methadone.
The results of this study indicate that participants often perceived buprenorphine as a helpful medication, while methadone was perceived as a harmful narcotic with negative side effects. In analyzing the results of this study, the authors concluded that differences in service structure between methadone and buprenorphine did not strongly influence treatment-related decisions. Rather, personal experiences with medications and community narratives surrounding the medications strongly influenced the participants’ treatment selection decisions.

Key Themes and Discussion Summary

Personal Narratives

Group attendees agreed with and discussed how personal experiences, including community narratives, can affect an individual’s selection of medication for treatment. Multiple group attendees noted that they had also been exposed to negative community narratives surrounding methadone.

Treatment Perceptions

Folks’ perceptions of substance use treatment was noted to have changed over the last decade, with medication for opioid use disorder being more widely accepted by community members. However, group members noted that that there is still stigma attached to medication for opioid use disorder and being in recovery.

Different Medication Effects

The differences between methadone and buprenorphine were further discussed and group members emphasized the difference in effects between these medications. Group members identified that methadone is widely known to have an increased effect than that of buprenorphine, which has a maximized ‘ceiling effect.’

Initial Treatment Entry vs Continued Treatment

The article being discussed focuses on selection of medication when entering treatment, but not selection in continued treatment. Group attendees highlighted this limitation in the study and acknowledged how selection and experiences may differ for individuals first entering treatment versus those who have been in treatment for a longer period of time.

More Meeting Summaries

Get in touch if you have any questions

(235) 342-1363